Effect of Population Doublings on Differentiation Capacity of Human Adipose-Derived Stem Cells: Establishing Standard Guidelines for Clinical Translational Applications
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2016, Vol 0, Issue 1
Abstract
Human adipose-derived stem cells (ASCs) are providing promise in clinical soft tissue replacement and repair. This study investigated the effect of multiple population doublings (PD) on ASCs growth rates and cell specific differentiation capacities (DC) to evaluate potential inter-individual specimen growth rates and DC for in vitro cell expansion use in future clinical applications. A decreased cell growth rate and DC were observed in long term cell culture when PD reached to 10.1. Early PD specimens with PD range from 1.6 to 6.2 showed the average population doubling time (PDT) as 5.1 days. There was no significant difference in ASCs growth rates among individual specimens (n=4, p=0.184). The DC over PD range 1.6 to 6.2 also showed no significant changes (osteogenic, n=3, p=0.472; chondrogenic, n=3, p=0.878; adipogenic, n=3, p=0.256). Our preliminary data showed the importance of PD for in vitro ASCs expansion. The cell growth rate and DC of ASCs were relatively stable up to PD 6.2. Beyond this PD, there was a trend of decreased growth rate and DC. Therefore, our study suggested that future in vitro expansion of ASCs for clinical application should consider limiting expansion of ASCs to PD 6.2 or less to ensure the cell quality. Use of specific PD instead of the non-specific passage numbers would be a better standardization of in vitro ASCs expansion for their clinical translational applications.
Authors and Affiliations
Spencer A. Brown
Keywords
Related Articles
- EP ID EP198182
- DOI 10.19070/2328-3548-SI02001
- Views 92
- Downloads 0
Heart-on-a-Chip Model for Cardiomyopathies
Heart-on-a-Chip Model for Cardiomyopathies
Improved Differentiation of Mesenchymal Stem Cells into Hepatocyte-like Cells using FGF4 and IGF-1 in 3D Culture
Human Umbilical Cord Mesenchymal Stem Cells (UCMSCs) are considered as an excellent candidate for cell therapy to treat end-stage liver disease. Fibroblast Growth Factor-4 (FGF4), Hepatocyte Growth Factor, and Insulin-li...
Search for Chemically Defined Culture Medium to Assist Initial Regeneration of Diseased Renal Parenchyma After Stem/Progenitor Cell Implantation
Before an intended implantation stem/progenitor cells are usually kept in the beneficial atmosphere of a selected culture medium. However, after implantation the situation is drastically changing for them. Yet stem/proge...
Stem Cell Therapy in Liver Cirrhosis
Cirrhosis results from different mechanisms of liver injury that lead to necroinflammation and fibrogenesis; Patients with liver cirrhosis often require liver transplantation but it is affected by many problems, includin...
Human Umbilical Cord Matrix - Derived Stem Cells Show Tropism Towards the Human Glioma Microenvironment
Objective: Glioblastoma multiforme (GBM) is an aggressive type of brain tumor in humans. The median survival of patients is a year after diagnosis. It is a great challenge to identify new therapeutic strategies that coul...